XHKG
2373
Market cap571mUSD
Oct 09, Last price
18.08HKD
1D
0.06%
1Q
1.63%
IPO
-37.66%
Name
Beauty Farm Medical & Health Industry Inc
Chart & performance
P/E
12.05
P/S
1.28
EPS
1.28
Div yield, %
2.88%
Shrs. gr., 5y
0.11%
Rev. gr., 5y
14.82%
Revenues
3.00b
+16.65%
Net income
318m
+39.00%
CFO
999m
+25.42%
Dividend
Aug 19, 20260.72 HKD/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Beauty Farm Medical and Health Industry Inc., established in 1993 and based in Shanghai, People's Republic of China, delivers comprehensive beauty and health management services across China. Its diverse offerings encompass traditional beauty treatments; advanced aesthetic medical services, including non-surgical options like energy-based therapies and injections, as well as surgical procedures; and specialized subhealth assessment and intervention programs. As of June 30, 2022, the company operated a network of 352 stores under its BeautyFarm, Palaispa, Neology, and CellCare brands, with 177 being directly owned and 175 franchised.
Legal address
Floor 4, Willow House, Cricket Square
Grand Cayman KY1-9010
KY
Grand Cayman KY1-9010
KY
Headquarters
上海市虹口区东大名路1089号12层1206单元
虹口区, SH 200080
CN
虹口区, SH 200080
CN
Other language
Beauty Farm Medical and Health Industry Inc.
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | |
| Income | |||||||
Revenues | |||||||
Cost of revenue | |||||||
Unusual Expense (Income) | |||||||
NOPBT | |||||||
NOPBT Margin | |||||||
Operating Taxes | |||||||
Tax Rate | |||||||
NOPAT | |||||||
Net income | |||||||
Dividends | |||||||
Dividend yield | |||||||
Proceeds from repurchase of equity | |||||||
BB yield | |||||||
| Debt | |||||||
Debt current | |||||||
Long-term debt | |||||||
Deferred revenue | |||||||
Other long-term liabilities | |||||||
Net debt | |||||||
| Cash flow | |||||||
Cash from operating activities | |||||||
CAPEX | |||||||
Cash from investing activities | |||||||
Cash from financing activities | |||||||
FCF | |||||||
| Balance | |||||||
Cash | |||||||
Long term investments | |||||||
Excess cash | |||||||
Stockholders' equity | |||||||
Invested Capital | |||||||
ROIC | |||||||
ROCE | |||||||
| EV | |||||||
Common stock shares outstanding | |||||||
Price | |||||||
Market cap | |||||||
EV | |||||||
EBITDA | |||||||
EV/EBITDA | |||||||
Interest | |||||||
Interest/NOPBT | |||||||